"Neurofibromatosis 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
Descriptor ID |
D016518
|
MeSH Number(s) |
C04.557.465.625.650.595.610.500 C04.557.580.600.580.590.655 C04.557.580.600.610.595.610.500 C04.700.645.655 C09.218.807.800.675.500 C09.647.675.500 C10.292.225.750.500 C10.292.910.600.500 C10.562.600.750 C10.574.500.549.700 C16.320.400.560.700 C16.320.700.645.655
|
Concept/Terms |
Neurofibromatosis 2- Neurofibromatosis 2
- Neurofibromatosis, Central, NF2
- Neurofibromatosis, Central, NF 2
- Bilateral Acoustic Neurofibromatosis
- Acoustic Neurofibromatoses, Bilateral
- Acoustic Neurofibromatosis, Bilateral
- Bilateral Acoustic Neurofibromatoses
- Neurofibromatoses, Bilateral Acoustic
- Neurofibromatosis, Bilateral Acoustic
- Neurofibromatosis II
- Neurofibromatosis IIs
- Neurofibromatosis, central type
- Neurofibromatosis Type 2
- Neurofibromatosis, Type II
- Neurofibromatoses, Type II
- Type II Neurofibromatoses
- Type II Neurofibromatosis
- Neurofibromatosis, Type 2
- Neurofibromatoses, Type 2
- Type 2 Neurofibromatoses
- Type 2 Neurofibromatosis
- NF2 (Neurofibromatosis 2)
- NF2s (Neurofibromatosis 2)
- Neurofibromatosis, Central NF2
- Central NF2 Neurofibromatoses
- Central NF2 Neurofibromatosis
- Neurofibromatoses, Central NF2
- Central Neurofibromatosis
- Central Neurofibromatoses
- Neurofibromatoses, Central
- Neurofibromatosis, Central
- Neurofibromatosis, Acoustic, Bilateral
- Neurofibromatosis Type II
Neuroma, Acoustic, Bilateral- Neuroma, Acoustic, Bilateral
- Acoustic Neurinoma, Bilateral
- Acoustic Neurinomas, Bilateral
- Bilateral Acoustic Neurinoma
- Bilateral Acoustic Neurinomas
- Neurinoma, Bilateral Acoustic
- Neurinomas, Bilateral Acoustic
Schwannoma, Acoustic, Bilateral- Schwannoma, Acoustic, Bilateral
- Acoustic Schwannomas, Bilateral
- Acoustic Schwannoma, Bilateral
- Bilateral Acoustic Schwannoma
- Bilateral Acoustic Schwannomas
- Schwannoma, Bilateral Acoustic
- Schwannomas, Bilateral Acoustic
Familial Acoustic Neuromas- Familial Acoustic Neuromas
- Acoustic Neuroma, Familial
- Acoustic Neuromas, Familial
- Familial Acoustic Neuroma
- Neuroma, Familial Acoustic
- Neuromas, Familial Acoustic
|
Below are MeSH descriptors whose meaning is more general than "Neurofibromatosis 2".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Germ Cell and Embryonal [C04.557.465]
- Neuroectodermal Tumors [C04.557.465.625]
- Neuroendocrine Tumors [C04.557.465.625.650]
- Neurilemmoma [C04.557.465.625.650.595]
- Neuroma, Acoustic [C04.557.465.625.650.595.610]
- Neurofibromatosis 2 [C04.557.465.625.650.595.610.500]
- Neoplasms, Nerve Tissue [C04.557.580]
- Nerve Sheath Neoplasms [C04.557.580.600]
- Neurofibroma [C04.557.580.600.580]
- Neurofibromatoses [C04.557.580.600.580.590]
- Neurofibromatosis 2 [C04.557.580.600.580.590.655]
- Neuroma [C04.557.580.600.610]
- Neurilemmoma [C04.557.580.600.610.595]
- Neuroma, Acoustic [C04.557.580.600.610.595.610]
- Neurofibromatosis 2 [C04.557.580.600.610.595.610.500]
- Neoplastic Syndromes, Hereditary [C04.700]
- Neurofibromatoses [C04.700.645]
- Neurofibromatosis 2 [C04.700.645.655]
- Otorhinolaryngologic Diseases [C09]
- Ear Diseases [C09.218]
- Retrocochlear Diseases [C09.218.807]
- Vestibulocochlear Nerve Diseases [C09.218.807.800]
- Neuroma, Acoustic [C09.218.807.800.675]
- Neurofibromatosis 2 [C09.218.807.800.675.500]
- Otorhinolaryngologic Neoplasms [C09.647]
- Neuroma, Acoustic [C09.647.675]
- Neurofibromatosis 2 [C09.647.675.500]
- Nervous System Diseases [C10]
- Cranial Nerve Diseases [C10.292]
- Cranial Nerve Neoplasms [C10.292.225]
- Neuroma, Acoustic [C10.292.225.750]
- Neurofibromatosis 2 [C10.292.225.750.500]
- Vestibulocochlear Nerve Diseases [C10.292.910]
- Neuroma, Acoustic [C10.292.910.600]
- Neurofibromatosis 2 [C10.292.910.600.500]
- Neurocutaneous Syndromes [C10.562]
- Neurofibromatoses [C10.562.600]
- Neurofibromatosis 2 [C10.562.600.750]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Neurofibromatoses [C10.574.500.549]
- Neurofibromatosis 2 [C10.574.500.549.700]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Neurofibromatoses [C16.320.400.560]
- Neurofibromatosis 2 [C16.320.400.560.700]
- Neoplastic Syndromes, Hereditary [C16.320.700]
- Neurofibromatoses [C16.320.700.645]
- Neurofibromatosis 2 [C16.320.700.645.655]
Below are MeSH descriptors whose meaning is more specific than "Neurofibromatosis 2".
This graph shows the total number of publications written about "Neurofibromatosis 2" by people in this website by year, and whether "Neurofibromatosis 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2020 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurofibromatosis 2" by people in Profiles.
-
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro Oncol. 2023 08 03; 25(8):1498-1506.
-
Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas. Ann Otol Rhinol Laryngol. 2020 Dec; 129(12):1229-1238.
-
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454.
-
An incidental but pathognomonic finding in renal allograft biopsy. Kidney Int. 2019 10; 96(4):1042.
-
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res. 2009 Aug 15; 15(16):5032-5039.
-
Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res. 2008 Sep; 466(9):2114-30.
-
Vascular dysplasia in neurofibromatosis type 2. Neurology. 2005 Jul 12; 65(1):163-4.
-
Advances in neurofibromatosis 2 (NF2): a workshop report. J Neurogenet. 2000 Jun; 14(2):63-106.
-
The ophthalmologic presentation of NF-2 in childhood. J Pediatr Ophthalmol Strabismus. 1993 Sep-Oct; 30(5):327-30.